Leptin (LEP) and leptin receptor (LEPR) overexpression are related to MS activity and progression, and peroxisome proliferator-activated receptor gamma co-activator 1-alpha (PGC1A) is able to affect the reactive oxygen species production in the pathogenesis of MS. Here, LEPR is linked to myeloid sarcoma.